LyonBioTech, a Technological Research Institute jointly developed by Lyonbiopole and Institut Pasteur, has been selected by the General Commission for Investment
Lyonbiopole, a global competitiveness cluster focused on the fight against human and animal infectious diseases and cancer, and Institut Pasteur, have announced that “LyonBioTech”, the Technological Research Institute in Infectious Diseases, has just been selected within the framework of a call for proposals in the Investments for the Future program.
LyonBioTech is proposing a totally new public/private partnership model, based on an integrated, interdisciplinary approach to R&D aiming to promote innovation in the study and treatment of infectious diseases, for the benefit of patients.
Download the press release